Type 2 Diabetes Patients Can Also Benefit From Fully Closed-Loop System
Even patients with type 2 diabetes can benefit from using a fully closed-loop insulin delivery system, also known as an artificial pancreas, according to an open-label crossover trial. In the randomized trial of 28 adults, patients spent a greater average proportion of time in target glucose range — 70 to 180 mg/dL (3.9 to 10.0 […]